Concepedia

Jan Stålhammar

JS

Statistics

Publications

23

Citations

691

H-Index

18

Active since

1987

Affiliations

Uppsala University(Current)

Karolinska Institutet

Merck & Co., Inc., Rahway, NJ, USA (United States)

Novartis (Switzerland)

Oslo University Hospital

Jan Stålhammar is an author at Uppsala University specializing in medicine, diabetes, and health policy.

ORCID

Top concepts

Publications per year

1987–2021

23

Publications

23

Prevalence and incidence of Type 2 diabetes and its complications 1996–2003—estimates from a Swedish population‐based study

Anna Ringborg, Peter Lindgren, Mats Martinell et al. · Diabetic Medicine · 2008 · 77 citations

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

Sverre E. Kjeldsen, Jan Stålhammar, Pål Hasvold et al. · Journal of Human Hypertension · 2009 · 60 citations · Full text

Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes

Anna Ringborg, Peter Lindgren, Dangyue Yin et al. · Diabetes & Metabolism · 2010 · 52 citations

, , +10

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data

Anna Ringborg, Mats Martinell, Jan Stålhammar et al. · International Journal of Clinical Practice · 2008 · 51 citations

Prescription drug use among diabetics—A population study

Dag Isacson, Jan Stålhammar · Journal of Chronic Diseases · 1987 · 48 citations

, , +5

1–5 of 23